Halzocort Tablet contains Deflazacort 6 mg, a synthetic glucocorticoid used for its potent anti-inflammatory and immunosuppressive properties. It is indicated for the management of various inflammatory and autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, polymyalgia rheumatica, and certain allergic disorders. Deflazacort acts by modulating the immune response, reducing inflammation, and suppressing the activity of immune cells, thereby alleviating symptoms associated with excessive immune activation. The drug is also employed in the treatment of Duchenne muscular dystrophy to improve muscle strength and function. Halzocort is administered orally and should be used under medical supervision, with dosage tailored according to the severity of the condition and patient response. Common side effects may include gastrointestinal disturbances, increased susceptibility to infections, hyperglycemia, and potential adrenal suppression with prolonged use. Caution is advised in patients with diabetes, hypertension, osteoporosis, or peptic ulcer disease. Abrupt discontinuation should be avoided to prevent adrenal insufficiency; tapering the dose gradually is recommended. Regular monitoring of clinical status and laboratory parameters is essential to ensure efficacy and minimize adverse effects. Halzocort Tablet offers an effective therapeutic option for inflammatory and autoimmune disorders when used appropriately.